Platelet GPIbα, GPIV and vWF polymorphisms and fatal pre-hospital MI among middle-aged men

Journal of Thrombosis and Thrombolysis

Volumn 26, Issue 2, 2008, Pages 91-96

  Pellikka, Minna ^a   Narhi, Lassi ^a   Perola, Markus ^b   Penttila, Antti ^c   Karhunen, Pekka J ^a,d   Mikkelsson, Jussi ^a,e  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

Myocardial infarction; Platelets; Polymorphism; von Willebrand factor

Indexed keywords

CD36 ANTIGEN; GLYCOPROTEIN IB ALPHA; VON WILLEBRAND FACTOR; ADHESION RECEPTOR; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOPSY; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FINLAND; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH; THROMBOCYTE; BLOOD; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RISK; THROMBOCYTE AGGREGATION;

ADULT; AGED; ANTIGENS, CD36; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DEATH, SUDDEN, CARDIAC; FINLAND; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PLATELET AGGREGATION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; VON WILLEBRAND FACTOR;

EID: 56049114404     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0072-2     Document Type: Article

References (43)

1. Williams MS, Bray PF (2001) Genetics of arterial prothrombotic risk states. Exp Biol Med 226:409-419
2. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Eng J Med 330:1041-1046
3. Norris RM (2000) The natural history of acute myocardial infarction. Heart 83:726-730
4. Friedlander Y, Siscovick DS, Weinmann S, Austin MA, Psaty BM, Lemaitre RN et al (1998) Family history as a risk factor for primary cardiac arrest. Circulation 97:155-160
5. Fuster V, Badimon JJ, Badimon L, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. N Eng J Med 326:242-250
6. Fuster V, Badimon JJ, Badimon L, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (II part). N Eng J Med 326:310-317
7. Davies MJ, Bland JM, Hangartner JR, Angelini A, Thomas AC (1989) Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischemic death. Eur Heart J 10:203-208
8. Bray PF (2000) Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol 7:284-289
9. Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, López JA (1999) Kozak sequence polymorphism of the glycoprotein (GP) Ibα gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 94:186-191
10. Keeney S, Cumming AM (2001) The molecular biology of von Willebrand disease. Clin Lab Haematol 23:209-230
11. Jurk K, Clemetson KJ, de Groot PG, Brodde MF, Steiner M, Savion N et al (2003) Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein 1b (GP1b): An alternative/backup mechanism to von Willebrand factor. FASEB J 17:1490-1492
12. Tandon NN, Kralisz U, Jamieson GA (1989) Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 264:7576-7583
13. Silverstein RL, Febbraio M (2000) CD36 and atherosclerosis. Curr Opin Lipidol 11:483-491
14. A polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscler Thromb Vasc Biol 19:2573-2578
15. Gelhaus A, Scheding A, Browne E, Burchard GD, Horstmann RD (2001) Variability of the CD36 gene in West Africa. Hum Mutat 18:444-450
16. Lacquemant C, Gaucher C, Delorme C, Chatellier G, Gallois Y, Rodier M et al (2000) Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. Kidney Int 57:1437-1443
17. Mikkelsson J, Perola M, Penttila A, Karhunen PJ (2001) Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death. Circulation 104:876-880
18. Ishida F, Ito T, Takei M, Shimodaira S, Kitano K, Kiyosawa K (2000) Genetic linkage of Kozak sequence polymorphism of the platelet glycoprotein Ibα with human platelet antigen-2 and variable number of tandem repeats polymorphism, and its relationship with coronary artery disease. Br J Haematol 111:1247-1249
19. Kaski S, Kekomaki R, Partanen J (1996) Systemic screening for genetic polymorphisms in human platelet glycoprotein Ib alpha. Immunogenetics 44:170-176
20. Meisel C, López JA, Stangl K (2004) Role of platelet glycoprotein polymorphisms in cardiovascular diseases. Naunyn-Schmiedelberg's Arch Pharmacol 369:38-54
21. Ozelo M, Costa DSP, Siqueira LH, Machado TMF, Castro V, Goncalves MS et al (2004) Genetic variability of platelet glycoprotein Ibα gene. Am J Hematol 77:107-116
22. Cadroy Y, Sakariassen KS, Charlet J-P, Thalamas C, Boneu B, Sie P (2001) Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood 98:3159-3161
23. Meisel C, Afshar-Kharghan V, Cascorbi I, Laule M, Stangl V, Felix SB et al (2001) Role of Kozak sequence polymorphism of platelet glycoprotein Ibα as a risk factor for coronary artery disease and catheter interventions. J Am Coll Cardiol 38:1023-1027
24. Kenny D, Muckian C, Fitzgerald DJ, Cannon CP, Shields DC (2002) Platelet glycoprotein ibalpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients. J Thromb Thrombolysis 13:13-19
25. Moshfegh K, Redondo M, Wuillemin WA, Julmy F, Meyer BJ (2000) Kozak sequence polymorphism of platelet adhesion receptor GPIbα gene related to variation in receptor density is associated with myocardial infarction. Eur Heart J 21(suppl):130(abstract)
26. Croft SA, Hampton KK, Daly ME, Steeds RP, Channer KS, Samani NJ (2000) Kozak sequence polymorphism in the platelet GPIbα gene is not associated with risk of myocardial infarction. Blood 95:2183-2184
27. Frank MB, Reiner AP, Schwartz SM, Kumar PN, Pearce RM, Arbogast PG et al (2001) The Kozak sequence polymorphism of platelet glycoprotein Ibα and risk of nonfatal myocardial infarction and nonfatal stroke in young women. Blood 97:875-879
28. Douglas H, Michaelides K, Gorog DA, Durante-Mangoni E, Ahmed N, Davies GJ et al (2002) Platelet membrane glycoprotein Ibα gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis. Heart 87:70-74
29. Douglas H, Gorog D, Ahmed N, Michaelides K, Durante-Mangoni E, Tuddenham EG et al (2000) Functional significance of GPIb alpha receptor polymorphism in patients with coronary artery disease. Eur Heart J 21(suppl Aug/Sept):66(abstract)
30. Kunicki TJ, Nugent DJ (2002) The influence of platelet glycoprotein polymorphisms on receptor function and risk for thrombosis. Vox Sanguinis 83:85-90
31. Ulrichts H, Vanhoorelbeke K, Cauwenberghs S, Vauterin S, Kroll H, Santoso S et al (2003) Von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism. Arterioscler Thromb Vasc Biol 23:1302-1307
32. Silverstein RL, Baird M, Lo SK, Yesner LM (1992) Sense and antisense cDNA transfection of CD36 (glocoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor. J Biol Chem 267:16607-16612
33. Leung LL, Li WX, McGregor JL, Albrecht G, Howard RJ (1992) CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. J Biol Chem 267:18244-18250
34. Englyst NA, Taube JM, Aitman TJ, Baglin TP, Byrne CD (2003) A novel role for CD36 in VLDL-enhanced platelet activation. Diabetes 52:1248-1255
35. Daviet L, McGregor JL (1997) Vascular biology of CD36: Roles of this new adhesion molecule family in different disease states. F.K. Schattauer Verlagsgesellschaft mbH (Stutgart). Thromb Haemost 78:65-69
36. Abumrad N, Coburn C, Ibrahimi A (1999) Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochem Biophys Acta 1441:4-13
37. Watanabe K, Ohta Y, Toba K, Ogawa Y, Hanawa H, Hirokawa Y et al (1998) Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency. Ann Nucl Med 12:261-266
38. Podrez EA, Febbraio M, Sheibani N, Schmitt D, Silverstein RL, Hajjar DP et al (2000) Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte generated reactive nitrogen species. J Clin Invest 105:1095-1108
39. Hajri T, Abumrad NA (2002) Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr 22:383-415
40. Janabi M, Yamashita S, Hirano K, Sakai N, Hiraoka H, Matsumoto K et al (2000) Oxidized LDL-induced NF-kappaB activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol 20:1953-1960
41. Diaz-Ricart M, Tandon NN, Carretero M, Ordinas A, Bastida E, Jamieson GA (1993) Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood. Blood 82:491-496
42. Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P et al (2002) Von Willebrand factor and coronary heart disease. Eur Heart J 23:1764-1770
43. Lip GYH, Blann AD (1995) Von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J 74:580-583